Verduijn, J
Milaneschi, Y
Schoevers, R A
van Hemert, A M
Beekman, A T F
Penninx, B W J H
Article History
Received: 22 July 2015
Accepted: 28 July 2015
First Online: 29 September 2015
Competing interests
: BWJHP has received research grants from NWO, BBRMI-NL, NIMH, EU-FP7 and Johnson & Johnson for research in NESDA. ATFB has been a speaker for Lundbeck and Eli Lilly, and received research grants from Astra Zeneca, Eli Lilly, Jansen and Shire for other studies, AMvH has been a speaker for Lundbeck and contributed to a web publication of GlaxoSmithKline B.V. The remaining authors declare no conflict of interest.